US Trends

where is vyvanse manufactured

Vyvanse Manufacturing Locations
Vyvanse (lisdexamfetamine dimesylate), primarily produced by Takeda (formerly Shire), shifted its core manufacturing to a facility in Germany in early 2024, as confirmed by official statements amid supply chain clarifications. This move addressed earlier concerns and distinguished it from unrelated generics like those from Glenmark, which handle different drugs. Packaging, however, faced separate issues at an overseas site in Ireland (Wasdell Europe Limited), leading to batch quarantines due to GMP non-compliance—but this didn't impact the active ingredient production in Germany.

Recent Updates and Supply Context

As of late 2025, no major shifts are reported post-TGA investigations, with Germany remaining the key hub for the active drug. Forum discussions, like those on Reddit's r/ausadhd, highlight community worries over shortages tied to packaging woes rather than core manufacturing flaws. Trending talks emphasize transparency: Takeda relies on third-party sites but maintains strict oversight.

Key Facts on Production Sites

  • Primary Active Ingredient : Germany (post-2024 relocation).
  • Packaging Challenges : Ireland facility (quality issues resolved via batch destruction).
  • API Suppliers : Multiple global players like Veranova, Cohance Lifesciences for raw materials, but branded Vyvanse stays under Takeda's control.
  • No U.S. Primary Site : While generics (e.g., Elite Pharma in NJ) emerge, brand stays overseas-focused.

Forum Buzz and Trending Insights

"Takeda confirmed manufacturing moved to Germany in early 2024. Glenmark rumors are off-base." – Echoed in ADHD communities.

Australian forums buzz with relief post-2025 TGA wrap-up, blending frustration over shortages with praise for clarified sourcing. Multi-view: Patients demand more visibility; regulators push GMP; Takeda stresses compliance. Speculation on future U.S./EU expansions lingers, but Germany holds steady into 2026.

TL;DR : Vyvanse's main manufacturing is in Germany since 2024, with past Ireland packaging hiccups now resolved—backed by Takeda and regulatory updates.

Information gathered from public forums or data available on the internet and portrayed here.